Gold Prices Hold Steady as Investors Monitor U.S.-Iran Tensions and Trump-Xi Summit 
DOJ May Drop Gautam Adani Fraud Charges Amid $10 Billion U.S. Investment Plan 
Asian Currencies Steady as Trump-Xi Summit, Inflation Concerns Boost Dollar 
TSMC Stake Sale Sends Vanguard Semiconductor Shares Lower 
Standard Chartered Appoints Manus Costello as New CFO Amid Leadership Reshuffle 
Oil Prices Hold Above $100 as Trump-Xi Meeting and Iran Conflict Keep Markets on Edge 
Asia-Pacific Banks Brace for Rising Credit Risks Amid Iran Conflict 
Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks 
New Zealand Budget 2026 Focuses on Fiscal Discipline and Infrastructure Investment 
U.S. Urges China to Help Curb Iran’s Actions in Gulf, Rubio Says 
YouTube and Snap Settle School District Mental Health Lawsuit Ahead of Major Social Media Trial 
OECD Sees Bank of Japan Raising Interest Rates to 2% by 2027 
Dollar Surges as Inflation Data Fuels Fed Rate Hike Expectations 
Australia Housing Tax Reform Sparks Debate Over Property Investor Tax Breaks 
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention 
CXMT Forecasts Record Revenue Growth as Global DRAM Prices Surge 
US, Japan Reaffirm Strong Currency Coordination Amid Yen Volatility 
GSK Consumer Healthcare Korea was revealed to have appointed a new chief executive officer, and it was revealed to be Shin Dong Woo, a former CEO of the company’s branch in Hong Kong.
According to The Korea Times, GSK Consumer Healthcare Korea announced the assignment of CEO Shin earlier this week. It was reported that the new chief has been with the company for 28 years and has led GSK in various international businesses - from consumer health care to general consumer goods.
He also led other health care firms such as Pfizer and Sanofi. Prior to his assignment as the new chief at GSK Consumer Healthcare Korea, he has been leading the Honk Kong unit for the last two years. During his tenure, he has many achievements, including boosting the business and building the foundation for its stability.
At Sanofi Korea, he became the first president of the He also completed the company's integration with Pfizer Consumer Healthcare, where he was CEO of the Korean branch and the Asia-Pacific region between 2015 and 2020.
Shin also became the very first president of the French multinational healthcare company’s Korean unit. He helped established the brand in the country and introduced major products that are now selling very well here., and this is not all. Shin has extensive experience in marketing as well as he worked at Coca-Cola, L’Oreal, and Fox Home Entertainment and was in charge of marketing and sales for more than a decade.
Meanwhile, Shin will lead GSK Consumer Healthcare Korea, which has recently changed its name to Haleon. This will be the company’s official name as it starts its consumer healthcare venture. The name means the company will also change all of its product packaging.
"With the announcement of 'Haleon' today, we are one step closer to our goal of becoming a consumer healthcare company,” Haleon’s CEO-nominee, Brian McNamara, said in a press release in February. “'Haleon' will stand as a leader in the consumer healthcare industry with the vision of delivering better daily health to mankind.”
“Haleon” is the outcome of the successful merging of Novartis in 2015 and Pfizer's consumer healthcare portfolio in 2019 over the past eight years.
